Hood River Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-195,721
| Closed | -$10.8M | – | 148 |
|
|
2021
Q2 | $10.8M | Sell |
195,721
-2,102
| -1% | -$116K | 0.32% | 87 |
|
|
2021
Q1 | $10.2M | Sell |
197,823
-19,612
| -9% | -$1.01M | 0.33% | 90 |
|
|
2020
Q4 | $9.42M | Buy |
217,435
+3,535
| +2% | +$153K | 0.31% | 87 |
|
|
2020
Q3 | $7.49M | Sell |
213,900
-20,950
| -9% | -$733K | 0.33% | 85 |
|
|
2020
Q2 | $12.6M | Buy |
234,850
+112
| +0% | +$5.99K | 0.56% | 68 |
|
|
2020
Q1 | $8.33M | Sell |
234,738
-2,666
| -1% | -$94.6K | 0.48% | 72 |
|
|
2019
Q4 | $11.3M | Buy |
237,404
+17,341
| +8% | +$828K | 0.49% | 77 |
|
|
2019
Q3 | $7.13M | Buy |
220,063
+1,933
| +0.9% | +$62.6K | 0.36% | 83 |
|
|
2019
Q2 | $10.9M | Buy |
218,130
+7,754
| +4% | +$387K | 0.51% | 78 |
|
|
2019
Q1 | $14.2M | Sell |
210,376
-8,691
| -4% | -$586K | 0.71% | 60 |
|
|
2018
Q4 | $10.1M | Buy |
219,067
+75,488
| +53% | +$3.48M | 0.6% | 69 |
|
|
2018
Q3 | $11.1M | Buy |
143,579
+4,851
| +3% | +$374K | 0.49% | 79 |
|
|
2018
Q2 | $11.7M | Buy |
138,728
+5,406
| +4% | +$455K | 0.6% | 75 |
|
|
2018
Q1 | $10.9M | Buy |
133,322
+2,705
| +2% | +$221K | 0.61% | 75 |
|
|
2017
Q4 | $7.47M | Buy |
130,617
+9,227
| +8% | +$527K | 0.43% | 78 |
|
|
2017
Q3 | $8.1M | Buy |
121,390
+2,546
| +2% | +$170K | 0.51% | 74 |
|
|
2017
Q2 | $6.12M | Buy |
118,844
+2,626
| +2% | +$135K | 0.42% | 77 |
|
|
2017
Q1 | $6.79M | Buy |
116,218
+3,929
| +3% | +$229K | 0.51% | 79 |
|
|
2016
Q4 | $4.69M | Buy |
+112,289
| New | +$4.69M | 0.41% | 77 |
|